These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2889976)

  • 41. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tamoxifen-induced regression of benign breast lesions.
    Ricciardi I; Ianniruberto A
    Obstet Gynecol; 1979 Jul; 54(1):80-4. PubMed ID: 377165
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Breast cancer risk management.
    Reeder JG; Vogel VG
    Clin Breast Cancer; 2007 Dec; 7(11):833-40. PubMed ID: 18269772
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Cecchini RS; Atkins JN; Bevers TB; Fehrenbacher L; Pajon ER; Wade JL; Robidoux A; Margolese RG; James J; Lippman SM; Runowicz CD; Ganz PA; Reis SE; McCaskill-Stevens W; Ford LG; Jordan VC; Wolmark N;
    JAMA; 2006 Jun; 295(23):2727-41. PubMed ID: 16754727
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tamoxifen in postmenopausal women a safety perspective.
    Robinson E; Kimmick GG; Muss HB
    Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Is breast cancer prevention by tamoxifen possible?].
    Namer M; Serin D; Ferrero JM
    Bull Cancer; 1995 Jul; 82 Suppl 3():155s-167s. PubMed ID: 7492828
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tamoxifen for prevention of breast cancer.
    Cersosimo RJ
    Ann Pharmacother; 2003 Feb; 37(2):268-73. PubMed ID: 12549959
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tamoxifen--the treatment of choice. Why look for alternatives?
    Baum M
    Br J Cancer; 1998 Sep; 78 Suppl 4(Suppl 4):1-4. PubMed ID: 9741780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skeletal effects of selective oestrogen receptor modulators (SERMs).
    Díez JL
    Hum Reprod Update; 2000; 6(3):255-8. PubMed ID: 10874570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should we discontinue tamoxifen in a patient with vision-threatening ocular toxicity related to low-dose tamoxifen therapy?
    Tsai DC; Chen SJ; Chiou SH; Lee AF; Lee FL; Hsu WM
    Eye (Lond); 2003 Mar; 17(2):276-8. PubMed ID: 12640432
    [No Abstract]   [Full Text] [Related]  

  • 53. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.
    Powles TJ; Hardy JR; Ashley SE; Farrington GM; Cosgrove D; Davey JB; Dowsett M; McKinna JA; Nash AG; Sinnett HD
    Br J Cancer; 1989 Jul; 60(1):126-31. PubMed ID: 2679843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-oestrogen therapy for breast cancer--a report on 300 patients treated with tamoxifen.
    Ward HW; Arthur K; Banks AJ; Bond WH; Brown I; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ostrowski MJ
    Clin Oncol; 1978 Mar; 4(1):11-7. PubMed ID: 639375
    [No Abstract]   [Full Text] [Related]  

  • 55. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
    Gail MH; Costantino JP; Bryant J; Croyle R; Freedman L; Helzlsouer K; Vogel V
    J Natl Cancer Inst; 1999 Nov; 91(21):1829-46. PubMed ID: 10547390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel agents to modulate oestrogen action.
    Dardes RC; Jordan VC
    Br Med Bull; 2000; 56(3):773-86. PubMed ID: 11255561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tamoxifen in breast cancer: viewpoint of the gynecologist].
    De Muylder X
    Acta Clin Belg; 1992; 47(3):178-84. PubMed ID: 1332348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tamoxifen for benign breast disease.
    Lancet; 1986 Feb; 1(8476):305. PubMed ID: 2868169
    [No Abstract]   [Full Text] [Related]  

  • 59. The breast cancer prevention trial: should women at risk take tamoxifen?
    McKeon VA
    J Obstet Gynecol Neonatal Nurs; 1999; 28(6 Suppl 1):34-8. PubMed ID: 10608495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
    Veronesi U; Maisonneuve P; Costa A; Sacchini V; Maltoni C; Robertson C; Rotmensz N; Boyle P
    Lancet; 1998 Jul; 352(9122):93-7. PubMed ID: 9672273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.